Skip to content
Stop using now Drug recall · FDA · Published April 2, 2014

Hospira Propofol Recall: Glass and Metal Particulates in Vials

Hospira recalls Propofol vials due to glass defects and metallic particulates. Check lot numbers and expiration dates for affected units.

🇺🇸 FDA recall #D-1547-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling Propofol Injectable Emulsion, 1%, because the interior neck of the glass vial has a defect that can cause visible embedded or free-floating metallic particulates to appear in the solution. This recall affects 844,300 vials distributed nationwide with expiration dates around May 2015. The record does not specify a remedy for consumers or patients. Read more at govinfonow.com/recall/46152-hospira-inc-recalls-propofol-injectable-emulsion-1-200-mg-20.

Source Summary by GovInfoNow · govinfonow.com/recall/46152-hospira-inc-recalls-propofol-injectable-emulsion-1-200-mg-20 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1547-2014

Cite this page

“Hospira Propofol Recall: Glass and Metal Particulates in Vials.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46152-hospira-inc-recalls-propofol-injectable-emulsion-1-200-mg-20. Based on FDA recall #D-1547-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1547-2014%22&limit=1).

The FDA announced on April 2, 2014, that Hospira Inc. is recalling Propofol Injectable Emulsion due to the presence of particulate matter in the vials. The agency classified the recall as Class I.

How to tell if you have it

  • Brand: Hospira
  • Product: Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), For I.V. Administration, Rx Only, 20 mL vial
  • NDC: 0409-4699-30
  • Lot codes: 29-614-DJ, 29-615-DJ, 29-616-DJ, 29-617-DJ, 29-628-DJ, 29-629-DJ, 29-630-DJ
  • Expiration date: 05/01/2015
  • Quantity: 844,300 vials

The hazard

A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include American Regent Papaverine HCl Injection Recall (July 24, 2026), Liebel-Flarsheim Optiray Imaging Bulk Package-350 Recall (July 31, 2026), and Sun Pharmaceutical DOXOrubin Liposome Injection Recall (May 12, 2026).

How to tell if you have this one

Look for Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL) in 20 mL vials manufactured by Hospira, Inc. Check for NDC 0409-4699-30 and Lot numbers: 29-614-DJ, 29-615-DJ, 29-616-DJ, 29-617-DJ, 29-628-DJ, 29-629-DJ, or 29-630-DJ. The expiration date for these lots is 05/01/2015.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Numbers

    Verify if your vials match the specific lot numbers (e.g., 29-614-DJ) and NDC 0409-4699-30 listed in the recall.

  2. Report to Manufacturer

    Contact Hospira Inc. in Lake Forest, IL, regarding the defect found during retain sample inspection.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 14 months after the firm started it.

1. Firm started the recall: Apr 2, 201412. FDA classified it Class I: Aug 20, 201423. Published in FDA’s Enforcement Report: Aug 27, 201434. FDA terminated the recall: May 29, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1547-2014 (April 2, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1547-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA